Allele-specific transcription factor binding in a cellular model of orofacial clefting.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
02 02 2022
Historique:
received: 03 08 2021
accepted: 17 01 2022
entrez: 3 2 2022
pubmed: 4 2 2022
medline: 11 3 2022
Statut: epublish

Résumé

Non-syndromic cleft lip with/without cleft palate (nsCL/P) is a frequent congenital malformation with multifactorial etiology. While recent genome-wide association studies (GWAS) have identified several nsCL/P risk loci, the functional effects of the associated non-coding variants are largely unknown. Furthermore, additional risk loci remain undetected due to lack of power. As genetic variants might alter binding of transcription factors (TF), we here hypothesized that the integration of data from TF binding sites, expression analyses and nsCL/P GWAS might help to (i) identify functionally relevant variants at GWAS loci, and (ii) highlight novel risk variants that have been previously undetected. Analysing the craniofacial TF TFAP2A in human embryonic palatal mesenchyme (HEPM) cells, we identified 2845 TFAP2A ChIP-seq peaks, several of which were located near nsCL/P candidate genes (e.g. MSX1 and SPRY2). Comparison with independent data suggest that 802 of them might be specific to craniofacial development, and genes near these peaks are enriched in processes relevant to nsCL/P. Integration with nsCL/P GWAS data, however, did not show robust evidence for co-localization of common nsCL/P risk variants with TFAP2A ChIP-seq peaks. This data set represents a new resource for the analyses of craniofacial processes, and similar approaches with additional cell lines and TFs could be applied to generate further insights into nsCL/P etiology.

Identifiants

pubmed: 35110662
doi: 10.1038/s41598-022-05876-7
pii: 10.1038/s41598-022-05876-7
pmc: PMC8810875
doi:

Substances chimiques

TFAP2A protein, human 0
Transcription Factor AP-2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1807

Informations de copyright

© 2022. The Author(s).

Références

Mossey, P. A., Little, J., Munger, R. G., Dixon, M. J. & Shaw, W. C. Cleft lip and palate. Lancet 374, 1773–1785 (2009).
pubmed: 19747722 doi: 10.1016/S0140-6736(09)60695-4
Leslie, E. J. & Marazita, M. L. Genetics of Orofacial Cleft Birth Defects. Curr. Genet. Med. Rep. 3, 118–126 (2015).
doi: 10.1007/s40142-015-0074-x
Tolarova, M. & Cervenka, J. Classification and birth prevalence of orofacial cleft. Am. J. Med. Genet. 75, 126–137 (1998).
pubmed: 9450872 doi: 10.1002/(SICI)1096-8628(19980113)75:2<126::AID-AJMG2>3.0.CO;2-R
Dixon, M. J., Marazita, M. L., Beaty, T. H. & Murray, J. C. Cleft lip and palate: understanding genetic and environmental influences. Nat. Rev. Genet. 12, 167–178 (2011).
pubmed: 21331089 pmcid: 3086810 doi: 10.1038/nrg2933
Grosen, D. et al. Risk of oral clefts in twins. Epidemiology 22, 313–319 (2011).
pubmed: 21423016 pmcid: 3089024 doi: 10.1097/EDE.0b013e3182125f9c
Grosen, D. et al. A cohort study of recurrence patterns among more than 54,000 relatives of oral cleft cases in Denmark: support for the multifactorial threshold model of inheritance. J. Med. Genet. 47, 162–168 (2010).
pubmed: 19752161 doi: 10.1136/jmg.2009.069385
Beaty, T. H., Marazita, M. L. & Leslie, E. J. Genetic factors influencing risk to orofacial clefts: today’s challenges and tomorrow’s opportunities. F1000 Res 5, 2800 (2016).
doi: 10.12688/f1000research.9503.1
Yu, Y. et al. Genome-wide analyses of non-syndromic cleft lip with palate identify 14 novel loci and genetic heterogeneity. Nat. Commun. 8, 14364 (2017).
pubmed: 28232668 pmcid: 5333091 doi: 10.1038/ncomms14364
Ludwig, K. U. et al. Imputation of orofacial clefting data identifies novel risk loci and sheds light on the genetic background of cleft lip ± cleft palate and cleft palate only. Hum. Mol. Genet. 26, 829–842 (2017).
pubmed: 28087736 pmcid: 5409059
Ludwig, K. U. et al. Meta-analysis reveals genome-wide significance at 15q13 for nonsyndromic clefting of both the lip and the palate, and functional analyses implicate GREM1 as a plausible causative gene. PLOS Genet. 12, e1005914–e1005914 (2016).
pubmed: 26968009 pmcid: 4788144 doi: 10.1371/journal.pgen.1005914
Ludwig, K. U. et al. Genome-wide meta-analyses of nonsyndromic cleft lip with or without cleft palate identify six new risk loci. Nat. Genet. 44, 968–971 (2012).
pubmed: 22863734 pmcid: 3598617 doi: 10.1038/ng.2360
Leslie, E. J. et al. Genome-wide meta-analyses of nonsyndromic orofacial clefts identify novel associations between FOXE1 and all orofacial clefts, and TP63 and cleft lip with or without cleft palate. Hum. Genet. 136, 275–286 (2017).
pubmed: 28054174 pmcid: 5317097 doi: 10.1007/s00439-016-1754-7
Leslie, E. J. et al. A multi-ethnic genome-wide association study identifies novel loci for non-syndromic cleft lip with or without cleft palate on 2p242, 17q23 and 19q13. Hum. Mol. Genet. 25, 2862–2872 (2016).
pubmed: 27033726 pmcid: 5181632
Sun, Y. et al. Genome-wide association study identifies a new susceptibility locus for cleft lip with or without a cleft palate. Nat. Commun. 6, 6414 (2015).
pubmed: 25775280 doi: 10.1038/ncomms7414
Beaty, T. H. et al. A genome-wide association study of cleft lip with and without cleft palate identifies risk variants near MAFB and ABCA4. Nat. Genet. 42, 525–529 (2010).
pubmed: 20436469 pmcid: 2941216 doi: 10.1038/ng.580
Moreno, L. M. et al. FOXE1 association with both isolated cleft lip with or without cleft palate, and isolated cleft palate. Hum. Mol. Genet. 18, 4879–4896 (2009).
pubmed: 19779022 pmcid: 2778374 doi: 10.1093/hmg/ddp444
Mangold, E. et al. Genome-wide association study identifies two susceptibility loci for nonsyndromic cleft lip with or without cleft palate. Nat. Genet. 42, 24–26 (2010).
pubmed: 20023658 doi: 10.1038/ng.506
Grant, S. F. A. et al. A genome-wide association study identifies a locus for nonsyndromic cleft lip with or without cleft palate on 8q24. J. Pediatr. 155, 909–913 (2009).
pubmed: 19656524 doi: 10.1016/j.jpeds.2009.06.020
Birnbaum, S. et al. Key susceptibility locus for nonsyndromic cleft lip with or without cleft palate on chromosome 8q24. Nat. Genet. 41, 473–477 (2009).
pubmed: 19270707 doi: 10.1038/ng.333
Rahimov, F. et al. Disruption of an AP-2α binding site in an IRF6 enhancer is associated with cleft lip. Nat. Genet. 40, 1341–1347 (2008).
pubmed: 18836445 pmcid: 2691688 doi: 10.1038/ng.242
Welzenbach, J. et al. Integrative approaches generate insights into the architecture of non-syndromic cleft lip with or without cleft palate. HGGADVANCE 2, 100038 (2021).
Thieme, F. & Ludwig, K. U. The role of noncoding genetic variation in isolated orofacial clefts. J. Dent. Res. 96, 1238–1247 (2017).
pubmed: 28732180 doi: 10.1177/0022034517720403
Zhang, F. & Lupski, J. R. Non-coding genetic variants in human disease. Hum. Mol. Genet. 24, R102–R110 (2015).
pubmed: 26152199 pmcid: 4572001 doi: 10.1093/hmg/ddv259
Greene, C. S. et al. Understanding multicellular function and disease with human tissue-specific networks. Nat. Genet. 47, 569–576 (2015).
pubmed: 25915600 pmcid: 4828725 doi: 10.1038/ng.3259
Liu, H. et al. Identification of common non-coding variants at 1p22 that are functional for non-syndromic orofacial clefting. Nat. Commun. 8, 14759 (2017).
pubmed: 28287101 pmcid: 5355807 doi: 10.1038/ncomms14759
Dhulipala, V. C., Welshons, W. V. & Reddy, C. S. Inhibition of human embryonic palatal mesenchymal cell cycle by secalonic acid D: A probable mechanism of its cleft palate induction. Orthod. Craniofac. Res. 7, 227–236 (2004).
pubmed: 15562586 doi: 10.1111/j.1601-6343.2004.00299.x
Yoneda, T. & Pratt, R. M. Mesenchymal cells from the human embryonic palate are highly responsive to epidermal growth factor. Science 213, 563 (1981).
pubmed: 7017936 doi: 10.1126/science.7017936
Milunsky, J. M. et al. TFAP2A mutations result in branchio-oculo-facial syndrome. Am. J. Hum. Genet. 82, 1171–1177 (2008).
pubmed: 18423521 pmcid: 2427243 doi: 10.1016/j.ajhg.2008.03.005
Kousa, Y. A. & Schutte, B. C. Toward an orofacial gene regulatory network. Dev. Dyn. 245, 220–232 (2016).
pubmed: 26332872 doi: 10.1002/dvdy.24341
Fornes, O. et al. JASPAR 2020: Update of the open-access database of transcription factor binding profiles. Nucl. Acids Res. 48, D87–D92 (2020).
pubmed: 31701148
Khan, A. et al. JASPAR 2018: Update of the open-access database of transcription factor binding profiles and its web framework. Nucl. Acids Res. 46, D260–D266 (2018).
pubmed: 29140473 doi: 10.1093/nar/gkx1126
Gerstein, M. B. et al. Architecture of the human regulatory network derived from ENCODE data. Nature 489, 208 (2012).
pubmed: 22972285 doi: 10.1038/489208b
Gey, G. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res 12, 264–265 (1952).
Wilderman, A., VanOudenhove, J., Kron, J., Noonan, J. & Cotney, J. High-resolution epigenomic atlas of human embryonic craniofacial development. Cell Rep. 23, 1581–1597 (2018).
pubmed: 29719267 pmcid: 5965702 doi: 10.1016/j.celrep.2018.03.129
Dixon, J. R. et al. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature 485, 376–380 (2012).
pubmed: 22495300 pmcid: 3356448 doi: 10.1038/nature11082
Huo, Y., Li, S., Liu, J., Li, X. & Luo, X.-J. Functional genomics reveal gene regulatory mechanisms underlying schizophrenia risk. Nat. Commun. 10, 670 (2019).
pubmed: 30737407 pmcid: 6368563 doi: 10.1038/s41467-019-08666-4
Benaglio, P. et al. Allele-specific NKX2-5 binding underlies multiple genetic associations with human electrocardiographic traits. Nat. Genet. 51, 1506–1517 (2019).
pubmed: 31570892 pmcid: 6858543 doi: 10.1038/s41588-019-0499-3
Schorle, H., Meier, P., Buchert, M., Jaenisch, R. & Mitchell, P. J. Transcription factor AP-2 essential for cranial closure and craniofacial development. Nature 381, 235–238 (1996).
pubmed: 8622765 doi: 10.1038/381235a0
Razaghi-Moghadam, Z., Namipashaki, A., Farahmand, S. & Ansari-Pour, N. Systems genetics of nonsyndromic orofacial clefting provides insights into its complex aetiology. Eur. J. Hum. Genet. 27, 226–234 (2019).
pubmed: 30254216 doi: 10.1038/s41431-018-0263-7
Brewer, S., Feng, W., Huang, J., Sullivan, S. & Williams, T. Wnt1-Cre-mediated deletion of AP-2α causes multiple neural crest-related defects. Dev. Biol. 267, 135–152 (2004).
pubmed: 14975722 doi: 10.1016/j.ydbio.2003.10.039
de Crozé, N., Maczkowiak, F. & Monsoro-Burq, A. H. Reiterative AP2a activity controls sequential steps in the neural crest gene regulatory network. Proc. Natl. Acad. Sci. USA 108, 155–160 (2011).
pubmed: 21169220 doi: 10.1073/pnas.1010740107
Mitchell, P. J., Timmons, P. M., Hébert, J. M., Rigby, P. W. & Tjian, R. Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. Genes Dev. 5, 105–119 (1991).
pubmed: 1989904 doi: 10.1101/gad.5.1.105
Xu, J. et al. FGF8 signaling alters the osteogenic cell fate in the hard palate. J. Dent. Res. 97, 589–596 (2018).
pubmed: 29342370 pmcid: 5958370 doi: 10.1177/0022034517750141
Green, R. M. et al. Tfap2a-dependent changes in mouse facial morphology result in clefting that can be ameliorated by a reduction in Fgf8 gene dosage. Dis. Model. Mech. 8, 31–43 (2015).
pubmed: 25381013
Medio, M. et al. Wnt/β-catenin signaling and Msx1 promote outgrowth of the maxillary prominences. Front. Physiol. 3, 375 (2012).
pubmed: 23055979 pmcid: 3457051 doi: 10.3389/fphys.2012.00375
Zhang, Z. et al. Rescue of cleft palate in Msx1-deficient mice by transgenic Bmp4 reveals a network of BMP and Shh signaling in the regulation of mammalian palatogenesis. Development (Camb, Engl) 129, 4135–4146 (2002).
doi: 10.1242/dev.129.17.4135
Rothstein, M. & Simoes-Costa, M. Heterodimerization of TFAP2 pioneer factors drives epigenomic remodeling during neural crest specification. Genome Res. 30, 35–48 (2020).
pubmed: 31848212 pmcid: 6961570 doi: 10.1101/gr.249680.119
Matsumura, K. et al. Sprouty2 controls proliferation of palate mesenchymal cells via fibroblast growth factor signaling. Biochem. Biophys. Res. Commun. 404, 1076–1082 (2011).
pubmed: 21195053 doi: 10.1016/j.bbrc.2010.12.116
Goodnough, L. H., Brugmann, S. A., Hu, D. & Helms, J. A. Stage-dependent craniofacial defects resulting from Sprouty2 overexpression. Dev. Dyn. 236, 1918–1928 (2007).
pubmed: 17576140 doi: 10.1002/dvdy.21195
Nakajima, A., Shuler, F. & C., Gulka, A. O. D., Hanai, J.-I.,. TGF-β Signaling and the Epithelial-Mesenchymal Transition during Palatal Fusion. Int. J. Mol. Sci. 19, 3638 (2018).
pmcid: 6274911 doi: 10.3390/ijms19113638
Chiquet, M., Blumer, S., Angelini, M., Mitsiadis, T. A. & Katsaros, C. Mesenchymal remodeling during palatal shelf elevation revealed by extracellular matrix and F-actin expression patterns. Front. Physiol. 7, 392 (2016).
pubmed: 27656150 pmcid: 5013070 doi: 10.3389/fphys.2016.00392
Antoni, D., Burckel, H., Josset, E. & Noel, G. Three-dimensional cell culture: A breakthrough in vivo. Int. J. Mol. Sci. 16, 5517–5527 (2015).
pubmed: 25768338 pmcid: 4394490 doi: 10.3390/ijms16035517
Wolf, C. J. et al. Development of an organotypic stem cell model for the study of human embryonic palatal fusion. Birth Defects Res. 110, 1322–1334 (2018).
pubmed: 30347137 pmcid: 6729140 doi: 10.1002/bdr2.1394
Hughes, A. J. et al. Engineered tissue folding by mechanical compaction of the mesenchyme. Dev. Cell 44, 165-178.e6 (2018).
pubmed: 29290586 doi: 10.1016/j.devcel.2017.12.004
Bishop, M. R. et al. Genome-wide enrichment of De Novo coding mutations in orofacial cleft trios. Am. J. Hum. Genet. 107, 124–136 (2020).
pubmed: 32574564 pmcid: 7332647 doi: 10.1016/j.ajhg.2020.05.018
Garland, M. A. et al. Role of epigenetics and miRNAs in orofacial clefts. Birth Defects Res. 112, 1635–1659 (2020).
pubmed: 32926553 pmcid: 7924905 doi: 10.1002/bdr2.1802
Stüssel, L. G. et al. MiRNA-149 as a candidate for facial clefting and neural crest cell migration. J. Dental Res. 220345211038203 (2021).
Landt, S. G. et al. ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Res. 22, 1813–1831 (2012).
pubmed: 22955991 pmcid: 3431496 doi: 10.1101/gr.136184.111
Carroll, T. S., Liang, Z., Salama, R., Stark, R. & de Santiago, I. Impact of artifact removal on ChIP quality metrics in ChIP-seq and ChIP-exo data. Front. Genet. 5, 75 (2014).
pubmed: 24782889 pmcid: 3989762 doi: 10.3389/fgene.2014.00075

Auteurs

Katharina L M Ruff (KLM)

School of Medicine and University Hospital Bonn, Institute of Human Genetics, University of Bonn, Bonn, Germany.

Ronja Hollstein (R)

School of Medicine and University Hospital Bonn, Institute of Human Genetics, University of Bonn, Bonn, Germany.

Julia Fazaal (J)

School of Medicine and University Hospital Bonn, Institute of Human Genetics, University of Bonn, Bonn, Germany.

Frederic Thieme (F)

School of Medicine and University Hospital Bonn, Institute of Human Genetics, University of Bonn, Bonn, Germany.

Jan Gehlen (J)

Centre for Human Genetics, University of Marburg, Marburg, Germany.

Elisabeth Mangold (E)

School of Medicine and University Hospital Bonn, Institute of Human Genetics, University of Bonn, Bonn, Germany.

Michael Knapp (M)

Institute for Medical Biometry, Informatics and Epidemiology IMBIE, University of Bonn, Bonn, Germany.

Julia Welzenbach (J)

School of Medicine and University Hospital Bonn, Institute of Human Genetics, University of Bonn, Bonn, Germany.

Kerstin U Ludwig (KU)

School of Medicine and University Hospital Bonn, Institute of Human Genetics, University of Bonn, Bonn, Germany. kerstin.ludwig@uni-bonn.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH